BeOne Medicines (ONC) Exchange Rate Effect (2015 - 2026)

BeOne Medicines (ONC) has reported Exchange Rate Effect for 12 consecutive years, with $19.3 million the latest figure, recorded in Q1 2026.

• In Q1 2026, Exchange Rate Effect rose 455.17% year-over-year to $19.3 million; the TTM figure through Mar 2026 stood at $75.9 million (up 394.19% YoY), while the FY2025 annual figure was $60.0 million, up 216.09% from the prior year.
• Exchange Rate Effect slipped to $19.3 million in Q1 2026 per ONC's latest filing, from $23.2 million in the prior quarter.
• Across five years, Exchange Rate Effect topped out at $64.5 million in Q4 2022 and bottomed at -$80.2 million in Q2 2022.
• Historically, Exchange Rate Effect has averaged -$2.9 million across 5 years, with a median of $9.0 million in 2022.
• Annual changes were most pronounced in 2022 — Exchange Rate Effect plunged 4247.95% — and 2024, when it jumped 5299.62%.
• BeOne Medicines' Exchange Rate Effect stood at $64.5 million in 2022, then slumped by 34.52% to $42.3 million in 2023, then plunged by 222.35% to -$51.7 million in 2024, then soared by 144.79% to $23.2 million in 2025, then declined by 16.59% to $19.3 million in 2026.
• Business Quant data shows ONC's Exchange Rate Effect at $19.3 million in Q1 2026, $23.2 million in Q4 2025, and $9.9 million in Q3 2025.